Methods of treating pediatric patients using dexmedetomidine
AssigneeHospira, Inc.
InventorsMarcelo Garcia da Rocha, Wayne Wisemandle, Dennis Stalker, Edward Koo
Life of this patent
Estimating the term…
Abstract
The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.
Claims7
A method of providing sedation or analgesia to a pediatric patient in need thereof, wherein the method comprises administering a ready to use liquid pharmaceutical premix composition comprising dexmedetomidine or a pharmaceutically acceptable salt thereof disposed within a sealed glass container at a concentration of about 0.005 to about 50 μg/mL to the pediatric patient;
- wherein the dexmedetomidine or pharmaceutically acceptable salt thereof is administered as a first loading dose at a concentration of between 0.2 to 1.5 μg/kg prior to a second maintenance dose at a concentration of between 0.005 to 1.5 μg/kg/hr;
- wherein the pediatric patient is 1 month to less than 17 years of age;
- and
- wherein the dexmedetomidine is administered as a continuous infusion for a period of time of less than about 36 hours.
Dependencies are inferred from the claim text.